Search

Your search keyword '"Amani-Bosse, C."' showing total 30 results

Search Constraints

Start Over You searched for: Author "Amani-Bosse, C." Remove constraint Author: "Amani-Bosse, C."
Sorry, I don't understand your search. ×
30 results on '"Amani-Bosse, C."'

Search Results

2. Optimal timing of antiretroviral treatment initiation in HIV-positive children and adolescents: a multiregional analysis from Southern Africa, West Africa and Europe

Catalog

Books, media, physical & digital resources

3. Optimal timing of antiretroviral treatment initiation in HIV-positive children and adolescents: a multiregional analysis from Southern Africa, West Africa and Europe

4. Acceptabilite´ du test VIH propose´ aux nourrissons dans les services pe´ diatriques, en Coˆ te d’Ivoire, Significations pour la couverture du diagnostic pe´diatrique

6. Mise en œuvre d'un système d'information pour optimiser la cascade de prévention de la prévention de la transmission mère-enfant du VIH avec dépistage maternel systématique à l'accouchement et suivi du couple mère-enfant dans le continuum de soins à Abidjan, Côte d'Ivoire - Le projet DEPISTNEO-VIH

7. Population Pharmacokinetics of Tenofovir in HIV-1-Infected Pregnant Women and Their Neonates (ANRS 12109)

9. Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission

10. Growth and mortality outcomes for different antiretroviral therapy initiation criteria in children ages 1-5 years: A causal modeling analysis

11. Incidence and risk factors of severe adverse events with nevirapine-based antiretroviral therapy in HIV-infected women. MTCT-Plus program, Abidjan, Côte d'Ivoire.

12. Early mixed feeding and breastfeeding beyond 6 months increase the risk of postnatal HIV transmission: ANRS 1201/1202 Ditrame Plus, Abidjan, Côte d'Ivoire.

13. Virological response and resistances over 12 months among HIV-infected children less than two years receiving first-line lopinavir/ritonavir-based antiretroviral therapy in Cote d'Ivoire and Burkina Faso: the MONOD ANRS 12206 cohort.

14. Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and Côte d'Ivoire: the MONOD ANRS 12206 non-inferiority randomised trial.

15. Optimal timing of antiretroviral treatment initiation in HIV-positive children and adolescents: a multiregional analysis from Southern Africa, West Africa and Europe.

16. Costs of Care of HIV-Infected Children Initiating Lopinavir/Ritonavir-Based Antiretroviral Therapy before the Age of Two in Cote d'Ivoire.

17. Missed opportunities of inclusion in a cohort of HIV-infected children to initiate antiretroviral treatment before the age of two in West Africa, 2011 to 2013.

18. Growth and Mortality Outcomes for Different Antiretroviral Therapy Initiation Criteria in Children Ages 1-5 Years: A Causal Modeling Analysis.

19. Association between age at antiretroviral therapy initiation and 24-month immune response in West-African HIV-infected children.

20. Antiretroviral treatment response of HIV-infected children after prevention of mother-to-child transmission in West Africa.

21. Evaluation of dried blood spot diagnosis using HIV1-DNA and HIV1-RNA Biocentric assays in infants in Abidjan, Côte d'Ivoire. The Pedi-Test DBS ANRS 12183 Study.

22. Universal HIV screening at postnatal points of care: which public health approach for early infant diagnosis in Côte d'Ivoire?

23. Health care resource utilization in untreated HIV-infected children in a pediatric programme, Abidjan, Côte d'Ivoire, 2004-2009.

24. Severe morbidity and mortality in untreated HIV-infected children in a paediatric care programme in Abidjan, Côte d'Ivoire, 2004-2009.

25. Plasma and intracellular tenofovir pharmacokinetics in the neonate (ANRS 12109 trial, step 2).

26. Pregnancy outcomes in women exposed to efavirenz and nevirapine: an appraisal of the IeDEA West Africa and ANRS Databases, Abidjan, Côte d'Ivoire.

27. Immunological response to highly active antiretroviral therapy following treatment for prevention of mother to child transmission of HIV-1: a study in Côte d'Ivoire.

28. Low retention of HIV-infected patients on antiretroviral therapy in 11 clinical centres in West Africa.

29. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.

30. Impact of nevirapine (NVP) plasma concentration on selection of resistant virus in mothers who received single-dose NVP to prevent perinatal human immunodeficiency virus type 1 transmission and persistence of resistant virus in their infected children.